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Abstract
Background: Genetic diseases are chronic conditions with relevant impact on the lives of patients and their families. In USA
and Europe it is estimated a prevalence of 60 million affected subjects, 75% of whom are in developmental age. A significant
number of newborns are admitted in the Neonatal Intensive Care Units (NICU) for reasons different from prematurity,
although the prevalence of those with genetic diseases is unknown. It is, then, common for the neonatologist to start a
diagnostic process on suspicion of a genetic disease or malformation syndrome, or to make and communicate these
diagnoses. Many surveys showed that the degree of parental satisfaction with the methods of communication of diagnosis
is low. Poor communication may have short and long-term negative effects on health and psychological and social
development of the child and his family. We draw up recommendations on this issue, shared by 6 Italian Scientific Societies
and 4 Parents’ Associations, aimed at making the neonatologist’s task easier at the difficult time of communication to parents
of a genetic disease/malformation syndrome diagnosis for their child.
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Methods:We used the method of the consensus paper. A multidisciplinary panel of experts was first established, based on
the clinical and scientific sharing of the thematic area of present recommendations. They were suggested by the Boards of
the six Scientific Societies that joined the initiative: Italian Societies of Pediatrics, Neonatology, Human Genetics, Perinatal
Medicine, Obstetric and Gynecological Ultrasound and Biophysical Methodologies, and Pediatric Genetic Diseases and
Congenital Disabilities. To obtain a deeper and global vision of the communication process, and to reach a better clinical
management of patients and their families, representatives of four Parents’ Associations were also recruited: Italian
Association of Down People, Cornelia de Lange National Volunteer Association, Italian Federation of Rare Diseases, and
Williams Syndrome People Association. They worked from September 2019 to November 2020 to achieve a consensus on
the recommendations for the communication of a new diagnosis of genetic disease.
Results: The consensus of experts drafted a final document defining the recommendations, for the neonatologist and/or
the pediatrician working in a fist level birthing center, on the first communication of genetic disease or malformation
syndrome diagnosis. Although there is no universal communication technique to make the informative process effective, we
tried to identify a few relevant strategic principles that the neonatologist/pediatrician may use in the relationship with the
family. We also summarized basic principles and significant aspects relating to the modalities of interaction with families in a
table, in order to create an easy tool for the neonatologist to be applied in the daily care practice. We finally obtained an
intersociety document, now published on the websites of the Scientific Societies involved.
Conclusions: The neonatologist/pediatrician is often the first to observe complex syndromic pictures, not always identified
before birth, although today more frequently prenatally diagnosed. It is necessary for him to know the aspects of genetic
diseases related to communication and bioethics, as well as the biological and clinical ones, which together outline the
cornerstones of the multidisciplinary care of these patients. This consensus provide practical recommendations on how to
make the first communication of a genetic disease /malformation syndrome diagnosis. The proposed goal is to make easier
the informative process, and to implement the best practices in the relationship with the family. A better doctor-patient/
family interaction may improve health outcomes of the child and his family, as well as reduce legal disputes with parents
and the phenomenon of defensive medicine.
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Background
Genetic diseases are chronic conditions with relevant im-
pact on the lives of patients and their families. Their
clinical presentation is heterogeneous, and include: mal-
formation syndromes which may be easily recognized (i.e.
Down syndrome); malformation syndromes with evident
phenotypes, but uncertain diagnosis only on clinical
ground; suspected genetic disorders without evident mal-
formations, which however involve organs and/or systems.
In USA and Europe, it is estimated a prevalence of 60 mil-
lion affected subjects (with an incidence of major malfor-
mations of 3% on the total of newborns), 75% of whom
are in developmental age (in about a quarter of cases the
diagnosis of such pathologies is made and communicated
after the pediatric age) [1, 2]. A significant number of
newborns are admitted in the Neonatal Intensive Care
Units (NICU) for reasons different than prematurity, al-
though the prevalence of those with genetic diseases is un-
known [1]. It is common, therefore, for the neonatologist
to start a diagnostic process on the suspicion of a genetic
disease or malformation syndrome, or to make and com-
municate these diagnoses. He is often the first to inform
parents, and communication is even more difficult when
such news is unexpected. The communication of diagno-
sis is part of the daily work of the neonatologist and
pediatrician and must be considered a medical act in all
respects, like any other diagnostic or therapeutic proced-
ure. For the neonatologist and the pediatrician of a birth-
ing center, informing parents that their baby is affected by
a malformation syndrome is one of the most delicate and
difficult experiences. The methods of communication of
diagnosis and the content of the information provided are
decisive for parents to control their emotions, ease the
painful effect of the news and find resources to face the
future. Many surveys assessed the degree of parental satis-
faction with the methods of communication of diagnosis
[3, 4]. They showed that dissatisfaction is avoidable, and
that it is not linked to the condition object of the commu-
nication, but to the modalities in which it is demonstrated
and explained [3]. Moreover, poor communication may
cause distrust and aversion towards doctors, and prevent
good cooperation between family and health care profes-
sionals. It has a long-term negative effect both on the abil-
ity to accept the diagnosis and to adapt to the new
situation, and on the developing relationships between
parents and children. Health and psychological and social
development of the child may be, then, adversely affected
for a long time. In the international literature specific
guidelines on this topic are few, and most are not recent
[5–9]. We draw up recommendations on this issue, shared
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by 6 Italian Scientific Societies and 4 Parents’ Associations,
aimed at making the neonatologist’s task easier, at the
time of communication to parents of a genetic disease/
malformation syndrome diagnosis for their child. The goal
is also to reassure families on the most suitable care path-
way, avoid raising inappropriate expectations and, at the
same time, optimize their resources (psychological, cul-
tural, socioeconomic) and implement skills and compe-
tences of their child.
Methods
We used the method of the consensus paper [10, 11]. A
multidisciplinary panel of experts was first established,
based on the clinical and scientific sharing of the the-
matic area which is object of the recommendations.
Doctors with specific expertise and experience, acquired
in communicating a genetic disease diagnosis, were identi-
fied. They were suggested by the Boards of the six Scien-
tific Societies which joined the initiative: Italian Societies
of Pediatrics, Neonatology, Human Genetics, Perinatal
Medicine, Obstetric and Gynecological Ultrasound and
Biophysical Methodologies, and Pediatric Genetic Diseases
and Congenital Disabilities. To obtain a deeper and global
vision of the communication process, and to reach a bet-
ter clinical management of patients and their families, rep-
resentatives of four Parents’ Associations were also
recruited: Italian Association of Down People, Cornelia de
Lange National Volunteer Association, Italian Federation
of Rare Diseases, and Williams Syndrome People Associ-
ation. They worked from September 2019 to November
2020 to achieve a consensus on the recommendations for
the communication of a new diagnosis of genetic disease.
Initially, a systematically revision of the literature was
made, inserting the terms “communication”, “diagnosis”,
“genetic/genomic disease”, “congenital malformation”,
“newborn” in the PubMed search engine. Papers pub-
lished in the last 30 years (from 1991 to date) were ana-
lyzed, also relating to thematic areas different from
clinical genetics, such as clinical psychology and bioeth-
ics, thus allowing an integration between the aspects of
genetic diseases related to communication and bioethics
and the biological and clinical ones, also considering the
new techniques of genomic diagnosis [5, 12–14]. After a
search in the literature databases by using the key words
above mentioned, we found a few dozen articles related
to general aspects of the communication skills of health-
care professionals and to genetic counselling, and about
ten among them were of the last decade [12–20]. Even
fewer were the studies found on prenatal counselling, as
well as on communication of neonatal genetic disorders
and/or single diseases, such as Down syndrome, cystic fi-
brosis, sickle cell anemia, thalassaemia, deafness [21–25].
A small nucleus of experts redacted the first report,
summarizing all available scientific information. It was
then submitted to the attention of a multidisciplinary
jury, composed by representatives of the Scientific Soci-
eties and by the Presidents/Coordinators of the Parents’
Associations involved. The document thus produced was
subsequently revised by an extended team of experts,
made also by the Presidents and Study Groups Coordi-
nators of the participating Scientific Societies.
Results
The consensus of experts drafted a final document de-
fining the recommendations, for the neonatologist or the
pediatrician working in a fist level birthing center, relat-
ing to the first communication of a genetic disease or
malformation syndrome diagnosis. Although there is no
universal communication technique to make the inform-
ative process effective, we tried to identify a few relevant
strategic principles which the neonatologist/pediatrician
may use in the relationship with the family. We also
summarized basic principles and the most relevant as-
pects on the modalities of interaction with families in a
table, to create an easy tool for health care professionals
to be applied in the daily care practice. We finally ob-
tained an intersociety document, now published on the
websites of the Scientific Societies involved.
Discussion
The communication of a diagnosis of a disease with
poor or disabling outcome, in which an effective thera-
peutic and support plan may not be proposed, is a nega-
tive event from an emotional and relational point of
view. Good communication is recognized as a pivotal
feature for healthcare professionals, and needed for the
quality of care they provide [26]. This ability is continu-
ously subjected to evaluation by patients, who always
consider it a priority among doctor’s skills [27]. More-
over, it is documented that physicians perceive them-
selves more effective in communicating with patients
when their clinical suspicion is confirmed by genetic
(cytogenetic and/or molecular) investigations. By con-
verse, families report that communicative effectiveness
does not depend on the diagnostic definition. The im-
portance attributed by doctors to diagnosis may reflect
their well-known tendency to give value to clinical tests
and to diagnostic or therapeutic procedures, while many
patients give more weight to the intrinsic importance of
the communication process (defined as personal utility)
[27]. However, in Italy there is to date no specific train-
ing course for the medical profession, during the degree
course, aimed at acquiring communication skills, nor
subsequently for the neonatologist (such cultural gap,
however, does not arise for medical genetics specialty,
where counseling is one of the fundamental topics of
training), during the Specialization School in Pediatrics.
Performing simulations of communication scenarios,
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within the specific clinical activities of each care setting,
may be useful for improving staff skills [28].
Improving the doctor-patient/family relationship may
have a favorable effect on health outcomes of children and
their parents, as well as reduce the phenomenon of defen-
sive medicine and the medico-legal disputes. To imple-
ment optimal doctor-patient relationships, the principles
of family-centered-care (such as, for example, collaborat-
ing with families and respecting their diversities, sharing
information and providing individualized care) must be
part of post-graduate training courses, policies and oper-
ational protocols of hospitals, and behaviors of neonat-
ology and pediatric departments staff [29].
Relationships between team members and parental
couple have a major impact in supporting parents’ role,
especially if continuity and uniformity of medical and
nursing care is guaranteed. Many behaviors of health
professionals negatively considered by parents widely re-
flect difficulties in communication or interpersonal skills,
such as a reduced amount of time dedicated to informa-
tion, or a modality without sensitivity, or also an attitude
excessively oriented to clinical aspects. Simple actions,
such as increasing attention to the time intended for
news transmission, simplifying and adapting language to
the interlocutor’s profile, recognizing the positive aspects
of the child, and especially the attitudes which offer sup-
port (practical and emotional) to parents’ role, may be
decisive. It is essential to understand families’ point of
view, because it allows to interpret their needs [30], and
therefore to identify possible solutions to the most press-
ing problems, sometimes apparently far from doctors’
competences.
In the case of the first communication of a genetic dis-
ease diagnosis, the neonatologist/pediatrician has the
aim of creating the relationship between health profes-
sionals and family. Thus, he lays the foundations to
guide parents towards the clinical goal and, through a
circular path, he supports and increases trust in their
child, giving further strength to the care process. At the
same time, he provides all the technical information on
the updated clinical and scientific data of the disease
which is object of the communication. The ability to ful-
fill these aims is partly related to the variable expertise
of neonatologists/paediatricians in approaching malfor-
mation syndromes and genetic disorders, with differ-
ences depending on whether the baby is born in a first
level birthing center or in a referral neonatal unit, even
more if it is located in a big and/or University Hospital.
However today, regardless of the clinical setting, neona-
tologists and pediatricians must know next generation
sequencing (NGS) techniques (which simultaneously
analyze millions of small DNA fragments), as they are an
effective diagnostic tool increasingly used within the
daily clinical activity. The current recommendation is to
perform these tests, as first, in presence of neurodeve-
lopmental disorders/intellectual disability, conditions
with genetic heterogeneity (e.g. ataxia) or non-specific or
unexplained clinical manifestations, also in light of their
greater diagnostic efficacy compared to molecular cyto-
genetic analyses. NGS (which include panel sequencing
and whole exome/genome sequencing, WES/WGS)
changed the diagnostic process in the suspicion of rare
disease, since diagnosis, unlike the traditional approach,
may be reached by a single examination. However, some
critical issues related to timing and indications, inter-
pretation, ethical aspects and accessibility, as well as ana-
lytical limits need still to be resolved [31]. Furthermore,
in cases with severe neonatal clinical onset, the timely
achievement of a genomic diagnosis, during the period
of hospitalization in the NICU, may have relevant effects
on clinical management. In addition to the potential
ability to modify treatments for the cases in which a cure
is possible, genomic diagnosis allows a reasoned refocus-
ing of the cure pathway, offers the possibility to reduce
the suffering of newborns and to provide support to
families, avoiding clinical obstinacy, disproportionate
care or futile treatments. Therefore, genomic informa-
tion may shift attention, in critical situations, from inva-
sive management to a different goal, which is the relief
of suffering [32]. This will be useful also for better com-
munication and relationship with families.
In the case of a malformative picture which is evident at
birth, communication is particularly challenging, espe-
cially if prenatal diagnosis is lacking. In these circum-
stances, the neonatologist must simultaneously fulfill, in
an urgent situation, therapeutic management (stabilizing
the adaptation to extrauterine life and preventing any
complications), diagnostic procedures (aimed at identify-
ing the cause of the clinical picture), and communication
with the parental couple. Parents, indeed, in a context of
extreme intensity and vulnerability, must be adequately
and timely informed, and involved in the care process.
The neonatologist is faced with pressing questions, such
as: “what and why did it happen? who is responsible for it?
may other problems arise? may they be cured? how will
he/she be when he/she grows up? ...” , and many others
will emerge in a short time. Communication with parents
in the first hours after birth is then difficult and often de-
cisive, and requires immediacy, sensitivity, experience and
adequate skills [33]. The information transmitted, the ver-
bal and non-verbal language used, the place and context
in which this occurs, will have a profound impact on the
family for many years [34]. Poor communication has, in
fact, a long-term negative effect both on the ability to
accept diagnosis and to adapt to the new situation, and on
the developing relationships between parents and chil-
dren. Therefore, health and psychological development of
the child may be adversely affected for a long time.
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There is no communication technique which may be
considered effective in all circumstances. However, we
may indicate 5 strategic principles:
1. Usage/empathy. It consists of the use of every
element that comes from parents (language,
attitude, arguments, etc. ...) for the primary aim of
communication, that is the creation of the
relationship between health care professionals and
family. We must avoid to openly contest the
parental couple: every “clash” may be a danger for
the relationship, and favor mechanisms of closure
and distrust.
2. Attitude of listening towards family.
3. Flexibility. The operator must adapt himself to the
interlocutor’s cultural and social level, removing
commonplaces and prejudices. The higher the level
of preconception is, the greater the degree of
stereotypy of the communicative moves increases.
This is followed by lowering of the therapeutic
efficacy, and removal of parents.
4. Parsimony. Clear messages, formulated with
suggestive style and sparingly delivered, are easy to
understand, generally effective, and get the most for
the least. They must not be overly specific, full of
technicalities and scientific references. Rather, it can
be useful to use anecdotes, metaphors or examples,
which lead to greater involvement of parents
allowing them to follow suggestions and
prescriptions with commitment and trust.
5. Restructuring. It means to insert the definition of a
problem within other systems of meaning. It
implies helping family to identify different points of
view on aspects of their life experienced, until that
moment, as particularly critical and painful. This is
useful and functional, also in order to guide parents
towards what “they can do” within the diagnostic-
therapeutic and/or support plan proposed by the
health care professional.
Communication is strategic if it respects these 5 prin-
ciples. To formulate specific interventions it is essential
to know the interlocutor, and to be able to recognize his
multiple signals. To grasp and understand all the pos-
sible traces that the family may provide in the relation-
ship, it is necessary to give all the time needed to
communication. The “psychic time” of parents, which is
requested for accepting a child unlike from what they
imagined until that moment, is often different than that
of the medical intervention. Recognizing this time and
being generous with one’s own have, then, a therapeutic
as well as an ethical value.
It may be useful to resort to some gimmicks to
improve communication effectiveness. It may be
advantageous, for example, while still maintaining
objectivity, to provide first the positive aspects of a
news, and then introduce the negative ones. Revers-
ing this order decreases the positive part of the in-
formation, because the negative news, which is
perceived as the most relevant, if presented first in-
hibits the perception of the positive one. To increase
communication effectiveness, speeches must be dir-
ectly reported to the interlocutor, avoiding imper-
sonal expressions. These phrases do not recognize to
families the specificity of their experience and the
particularity of the interaction in which they are in-
volved. A personalized communication takes into ac-
count the subject, and is full of references to his
experience. It is preferable to use the first plural
person (we), instead of the first and second singular
one. In this way, it is transmitted the message of be-
ing involved in the relationship, and a greater will-
ingness to perform specific behaviors may be
obtained. A continuous and direct eye contact re-
flects true interest, and it guarantees active listening
[35]. In Table 1 are summarized the indications for
the neonatologists/pediatricians on the first commu-
nication of genetic disease/malformation syndrome
diagnosis. It may be a useful and practical tool to
make easier the informative process with the parents
of these patients, as well as to implement the best
practices in the relationship with families. Among
the suggestions provided, it is particularly remark-
able the relevance of the multi-specialty/multi-pro-
fessional approach to these patients, even more
during the difficult time of the first communication
of diagnosis. The clinical geneticist and/or neonat-
ologist or other specialist who has direct knowledge
of the newborn, with competence on the disease ob-
ject of the diagnosis and, if possible, the responsibil-
ity of care, may have a key role in the interaction
with parents. However, since patients with genetic
diseases are frequently burdened by the occurrence
of malformations affecting multiple organs and sys-
tems, other specialists (e.g. pediatric surgeon) and
health professionals (e.g. physiotherapist) should be
involved or available. The presence of the cultural
mediator is useful for those born to foreign parents.
Likewise, trusted persons and representative of the
reference Association (if available) must be taken
into consideration within the informative process,
since its initial steps. The synergy of different sup-
porting figures with specific skills and competences,
as well as a multidisciplinary management (including
gynecologist, obstetrician, neonatologist, surgeon,
psychologist ...), may guarantee to families a global,
integrated and continuous care, and reduce the risk
of disorientation or sense of abandonment. In the
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Table 1 Indications for the neonatologist and the pediatrician to make easier the communication of a genetic disease and/or
malformation syndrome diagnosis, and to implement the best practices in the relationship with families [36, 37]
When • The first interview with the parents/family members should be carried out at the time of the clinical diagnosis (postponing the
communication until the karyotype is available, for example in the case of Down syndrome, is considered unprofessional and
intolerable by the family).
• In cases of long-lasting diagnostic pathways (for example diagnosis of genetic and/or genomic diseases made by array-CGH/NGS
techniques), it is necessary to share with parents the different moments and results obtained during the diagnostic process
• In cases where the diagnosis is not defined, it is however possible to make a functional diagnosis, to which refer to for care program
and follow-up planning.
Who • Clinical geneticist and/or neonatologist or other specialist who has direct knowledge of the newborn, with competence on the
disease object of the diagnosis and, if possible, the responsibility of care, owing to their expertise regarding the syndrome as well as
in explaining methods and timing of diagnostic tests.
• Genetic diseases are frequently burdened by the presence of malformations affecting multiple organs and systems and require
multi-specialty/multi-professional management. Therefore, other specialists (e.g. pediatric surgeon) and health professionals (e.g.
physiotherapist) should be present or available.
• For those born to foreign parents the presence of the cultural mediator is useful.
With whom • The first meeting to communicate the diagnosis should be carried out with both parents (avoiding the presence of other figures not
directly involved in care).
• If the mother is not in good clinical conditions, the first communication may be made with the father (with whom times and
methods to inform the mother should be agreed).
• The interview must be carried out in front of the newborn. His presence allows parents to be guided towards his physiological
characteristics, skills, and potential.
• In subsequent meetings, the involvement of family pediatrician, other specialists/health professionals, other family members/trusted
persons, representative of the reference Association (if available) may be agreed. A multidisciplinary management (gynecologist,
obstetrician, neonatologist, surgeon, psychologist ...), may guarantee to families a global, integrated and continuous care, and reduce
the risk of disorientation or sense of abandonment.
Where A private environment must be identified:
• free from possible interruptions (by telephone, other colleagues, etc. ...);
• available exclusively to parents at the end of the interview.
How • In a proactive way, with empathy and respect.
• Balance honesty and frankness (it is better a sincere “I don’t know” than incorrect or inaccurate indications, with negative
repercussions on the whole life of the child and the family) with the need of parents to maintain hope for the survival of their baby.
• Speak simply and clearly, using common language and minimizing jargon.
• Avoid the attitude of over-describing the clinical aspects.
• Refer to the child by name.
• Ensure continuous and direct eye contact.
• Arrange distances in the range of 50–100 cm, i.e. between “personal” and “social”, placing the chairs side by side and not in front
(the interposition of the desk may be perceived as an obstacle to communication).
• Accept the experience of family members and their vision of things, without directly contesting them.
• Provide practical and emotional support to the process of remodeling parents’ role.
• Suspend critical judgment, interpretations and “thought readings” during the interview.
• Provide first the positive aspects of a news, and then introduce the negative ones.
• Use the first plural person (we) instead of the first or second singular one.
• Avoid impersonal expressions, and directly refer to the experience of parents.
• Assess parents’ knowledge, their cultural background, and ethical visions, as well as the ability to understand what is explained to
them.
• Facilitate questions and requests from parents with opening speeches.
How long • First meeting without time limits, however avoiding overflowing interviews that lose effectiveness and increase the risk of
misunderstandings.
• Provide more meetings, as needed, with different methods and professionals.
• In any case, dedicate all the time you need to communication. The “psychic time” of parents, necessary for accepting a child unlike
from what they imagined until that moment, is often different than that of the medical intervention. Recognizing this time and
being generous with one’s own have, then, a therapeutic as well as an ethical value.
What • Provide updated information on the main characteristics of the newborn’s disease, reporting only the most frequent complications,
without listing the rarest or most unlikely ones (which indicate theoretical knowledge, but which do not give any benefit to the
family).
• Explain genetic and/or genomic diagnostic procedures, documenting the clinical indications.
• Perform a physical examination of the newborn together with the parents, underlining his physiological features.
• Formulate an individualized and realistic prognosis (not theoretical and applicable in a generic way to other patients with the same
disease), and perform a reproductive counseling.
• Describe the care program and provide information on follow-up, reference center and local services.
With which supports/
helps
• Informatic and/or written material (brochures, information booklets also relating to the presentation of the reference Association),
guided web navigation in order to avoid that misleading information can disrupt the correct care or adaptation process.
• Parents/families’ associations, institutions.
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meantime, such approach may avoid the risks associ-
ated with the autonomous search for medical infor-
mation by families. In regard to this, a guided web
navigation may be crucial, since misinformation from
uncertified internet can jeopardize the efforts of a
correct communication.
The pediatrician-parents relationship is a communica-
tive situation in which the goal is common and shared.
The strategic mandate of the pediatrician consists of 1)
leading the relationship; 2) accompanying parents to-
wards the clinical goal; 3) keeping always high motiv-
ation and trust; 4) ensuring good levels of compliance
and managing any unexpected events.
Sometimes fulfilling this task is for the pediatrician a
simple, spontaneous and immediate activity. In fact, with
many parents it is not necessary to consciously assume a
strategic attitude. These are situations in which communi-
cation simply flows and generates balances functional to
the treatment, which facilitate doctor’s work. Other times,
however, the relationship with family members is critical,
and care may be affected. In these cases, both patient’s
well-being and that of the healthcare worker are at risk.
This happens, for example, with the parents of children
with genetic disease, with whom communication is more
difficult. Indeed, they are discouraged and question the
role and the therapeutic “power” of those who cover it.
The pediatrician, in these cases, will be strategic if he is
able to behave not only as an expert clinician, but also as a
process expert. The latter knows how to pick up signals,
even the weak ones, and uses them to promote the thera-
peutic relationship, to generate behaviors in families that
are tuned to the achievement of the clinical goal.
Conclusions
The neonatologist/pediatrician is often the first to ob-
serve complex syndromic pictures, not always identified
in the prenatal period. He must be aware of all aspects
around the genetic diseases, including communication,
bioethics, and law [38–44] in view of a multidisciplinary
care of the affected newborns and children.
A genetic diagnosis allows the families to feel less fra-
gile, regardless of the benefit that it may have on the
clinical management. NGS techniques allowed to pro-
vide early genetic counseling [45–48]. When promptly
obtained, they may support and guide clinicians to the
most appropriate clinical management and communica-
tive approach, avoiding futile and/or disproportionate
treatments [32], as well as further unnecessary separa-
tions between children and their parents [49].
This consensus provides neonatologists and pediatri-
cians with practical recommendations around the first
communication of a genetic disease/malformation syn-
drome diagnosis. The indications reported may be a useful
tool to make easier the informative process, and to
implement the best practices in the relationship with fam-
ilies. Communication must not be a marginal or second-
ary clinical activity. By converse, it requires a careful
attention of operators, also considering its clinical and so-
cioeconomic implications on the short and long term. In-
deed, a better doctor-patient/family interaction may
improve several health outcomes of the child and his fam-
ily. In addition, it may also reduce the legal disputes with
parents and the phenomenon of defensive medicine.
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